Hs. White et al., ANTICONVULSANT ACTIVITY OF THE GAMMA-AMINOBUTYRIC-ACID UPTAKE INHIBITOR NYL-4,5,6,7-TETRAHYDROISOXAZOLO[4,5-C]PYRIDIN-3-OL, European journal of pharmacology, 236(1), 1993, pp. 147-149
The N-4,4-diphenyl-3-butenyl derivative of the glial selective gamma-a
minobutyric acid (GABA) uptake inhibitor 4,5,6,7-tetrahydroisoxazolo[4
,5c]pyridin-3-ol (N-DPB-THPO), was tested for its ability to block sou
nd-induced seizures in the audiogenic seizure-susceptible Frings mouse
model of epilepsy. Following intracerebroventricular (i.c.v.) adminis
tration, N-DPB-THPO blocked tonic hindlimb extension in a dose- and ti
me-dependent manner. At the doses tested no gross behavioral effects w
ere noted.